TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).

Ravi Vij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.